Clinical Trial

Predictors of Treatment Response to Stellate Ganglion Block in Cervical Radicular Pain

Completed
View on ClinicalTrials.gov →
Summary
Purpose: Stellate ganglion block (SGB) is a procedure that uses ultrasound to guide a needle near a group of nerves in the neck called the stellate ganglion. A local anesthetic is then injected to block pain signals. This procedure has recently shown promise as a treatment for cervical radicular pain - pain that travels from the neck down into the arm, usually caused by a pinched nerve in the spine. While SGB appears to be effective for many patients, not all patients respond equally well. Currently, there is no way to predict before the procedure which patients are likely to benefit and which are not. Identifying such predictors would help doctors select the right patients for this treatment and avoid unnecessary procedures. Study Question: This study aimed to determine whether specific clinical characteristics or imaging findings on MRI could predict whether a patient would have a successful pain response after receiving SGB for cervical radicular pain. Methods: This was a retrospective study that reviewed the medical records of patients who received ultrasound-guided SGB at a single medical center between October 2018 and April 2023. Patients were included if they had one-sided arm pain caused by a pinched nerve confirmed on MRI and had not improved after at least one month of standard treatments such as medication and physical therapy. Information collected from medical records included patient age, sex, body mass index, presence of diabetes or hypertension, pain severity (measured on a 0-to-10 scale), duration of symptoms, and neck disability scores. Imaging findings from cervical MRI were also evaluated, including the degree of nerve compression, the cause of the compression (soft disc herniation versus bony overgrowth), the condition of the spinal canal, disc degeneration, and the amount of fatty changes in the small muscles along the back of the neck (called the multifidus muscles). Hypothesis: The study hypothesized that certain imaging-based factors - specifically, significant fatty degeneration of the cervical multifidus muscles and bony overgrowth as the main cause of nerve compression - would be associated with a poorer response to SGB at 3 months after the procedure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-12.
Trial Details
NCT Number NCT07476235
Lead Sponsor Asan Medical Center
Conditions Radiculopathy, Cervical Region
Enrollment 90 participants
Start Date 2024-10-08
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-18